X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with SHASUN PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs SHASUN PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD SHASUN PHARMA WYETH LTD/
SHASUN PHARMA
 
P/E (TTM) x 27.7 123.9 22.4% View Chart
P/BV x 5.3 8.5 62.7% View Chart
Dividend Yield % 1.3 0.2 546.3%  

Financials

 WYETH LTD   SHASUN PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
SHASUN PHARMA
Mar-14
WYETH LTD/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,04494 1,108.7%   
Low Rs81846 1,793.9%   
Sales per share (Unadj.) Rs298.6214.2 139.4%  
Earnings per share (Unadj.) Rs57.25.3 1,072.7%  
Cash flow per share (Unadj.) Rs58.415.8 369.2%  
Dividends per share (Unadj.) Rs17.001.00 1,700.0%  
Dividend yield (eoy) %1.81.4 127.6%  
Book value per share (Unadj.) Rs249.553.3 467.7%  
Shares outstanding (eoy) m22.7256.62 40.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.10.3 955.7%   
Avg P/E ratio x16.313.1 124.2%  
P/CF ratio (eoy) x15.94.4 360.8%  
Price / Book Value ratio x3.71.3 284.8%  
Dividend payout %29.718.7 158.5%   
Avg Mkt Cap Rs m21,1573,958 534.6%   
No. of employees `0000.5NA-   
Total wages/salary Rs m4002,164 18.5%   
Avg. sales/employee Rs Th13,787.4NM-  
Avg. wages/employee Rs Th813.0NM-  
Avg. net profit/employee Rs Th2,643.3NM-  
INCOME DATA
Net Sales Rs m6,78312,127 55.9%  
Other income Rs m353229 153.7%   
Total revenues Rs m7,13612,356 57.8%   
Gross profit Rs m1,6171,009 160.3%  
Depreciation Rs m27594 4.5%   
Interest Rs m6415 1.3%   
Profit before tax Rs m1,938230 843.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632-73 -869.4%   
Profit after tax Rs m1,301302 430.5%  
Gross profit margin %23.88.3 286.5%  
Effective tax rate %32.6-31.7 -103.1%   
Net profit margin %19.22.5 769.5%  
BALANCE SHEET DATA
Current assets Rs m6,9846,884 101.4%   
Current liabilities Rs m2,0568,456 24.3%   
Net working cap to sales %72.6-13.0 -560.6%  
Current ratio x3.40.8 417.2%  
Inventory Days Days9962 161.1%  
Debtors Days Days24108 22.3%  
Net fixed assets Rs m2444,970 4.9%   
Share capital Rs m227113 200.5%   
"Free" reserves Rs m5,4412,875 189.3%   
Net worth Rs m5,6683,020 187.7%   
Long term debt Rs m251,817 1.4%   
Total assets Rs m7,90113,347 59.2%  
Interest coverage x353.31.6 22,746.0%   
Debt to equity ratio x00.6 0.7%  
Sales to assets ratio x0.90.9 94.5%   
Return on assets %16.55.4 307.6%  
Return on equity %22.910.0 229.4%  
Return on capital %34.013.3 255.5%  
Exports to sales %0.246.4 0.5%   
Imports to sales %36.314.2 255.1%   
Exports (fob) Rs m155,622 0.3%   
Imports (cif) Rs m2,4651,728 142.7%   
Fx inflow Rs m155,843 0.3%   
Fx outflow Rs m2,6772,173 123.2%   
Net fx Rs m-2,6623,669 -72.5%   
CASH FLOW
From Operations Rs m923398 232.2%  
From Investments Rs m317-1,635 -19.4%  
From Financial Activity Rs m-4811,309 -36.8%  
Net Cashflow Rs m75971 1,066.2%  

Share Holding

Indian Promoters % 0.0 39.2 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 3.6 313.9%  
FIIs % 7.2 17.6 40.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 39.6 76.8%  
Shareholders   21,978 20,750 105.9%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   CADILA HEALTHCARE  TTK HEALTHCARE  DR. DATSONS LABS  CIPLA  GSK PHARMA  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Day Flat; Oil and Gas Stocks Lead Losses(Closing)

After opening the day in red, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS